Trademarkia Logo

Canada

C$
Trademark Search in Canada
LUXNUVIZ

View On IC.GC.CA

LUXNUVIZ
APPROVED

on 6 Feb 2025

Last Applicant/ Owned by

PRINCIPIA BIOPHARMA Inc.

55 Corporate DriveBridgewater, NJ 08807

US

Serial Number

2151440 filed on 2th Dec 2021

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

LUXNUVIZ

Trademark usage description

pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders; pharmaceutical preparations for human use that modu Read More

Classification Information

Class [005]
Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for use in the treatment of autoinflammatory diseases; pharmaceutical preparations for the prevention and treatment of inflammatory diseases and disorders, namely inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory muscle diseases, and inflammatory pelvic diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations for preventing and treating diseases and disorders of the skin and blood; pharmaceutical preparations for preventing and treating lesions and tumors.

Classification kind code

11

Mark Details

Serial Number

2151440

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 26
on 6th Feb 2025		Approved
Submitted for opposition 27
on 6th Feb 2025		Approval Notice Sent
Submitted for opposition 67
on 27th Sept 2024		Agent Name Changed
Submitted for opposition 20
on 23rd Jul 2024		Examiner's First Report
Submitted for opposition 22
on 4th Jul 2024		Search Recorded
Submitted for opposition 287
on 12th Jul 2022		Pre-Assessment Letter Sent
Submitted for opposition 135
on 6th Jun 2022		Amendment to Application
Submitted for opposition 30
on 2th Dec 2021		Filed
Submitted for opposition 1
on 2th Dec 2021		Created
Submitted for opposition 31
on 2th Dec 2021		Formalized